The contract is aimed at identifying new avenues of research for better understanding the beneficial effects on human health of the milk components and its derivatives.
The research will focus in particular on studying their nutritional and therapeutic values. The financial terms of the deal were not disclosed.
The contract will also enable Rhenovia to expand the application of its technology from medical products to food markets, and Sodiaal to better understand the effects of food on human health (especially on people’s predisposition to neurodegenerative diseases) for the best benefit of consumers.
Source: Rhenovia Pharma SAS
© FoodBev Media Ltd 2024